Role of Apolipoprotein A1 in PPAR Signaling Pathway for Nonalcoholic Fatty Liver Disease

Table 2

MLR results of risk factors of NAFLD according to serum APOA1 quintiles.

APOA1		Model 1		Model 2		Model 3
Quartile		value	OR (95% CI)	value	OR(95% CI)	value	OR (95% CI)
Q1	3300		1		1		1
Q2	3165	<0.000	0.814 (0.731-.905)	0.806	0.984 (0.869-1.115)	0.479	1.055 (0.913-.220)
Q3	3156	<0.000	0.568 (0.508-0.636)	0.002	0.812 (0.711-0.927)	0.005	0.790 (0.670-.932)
Q4	3202	<0.000	0.382 (0.339-0.431)	<.0001	0.625 (0.539-0.724)	<.0001	0.562 (0.452-.699)

Note: model 1 does not adjust for confounding factors; model 2 adjusted age, gender, and body mass index; model 3 adjusted age, sex, body mass index, waist circumference, uric acid, systolic blood pressure, diastolic blood pressure, total cholesterol, triacylglycerol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood glucose, alanine aminotransferase, aspartate aminotransferase, and glutamyltranspeptidase.